• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

突变型p53介导的肿瘤分泌组:连接肿瘤细胞与基质细胞

Mutant p53-Mediated Tumor Secretome: Bridging Tumor Cells and Stromal Cells.

作者信息

Qiu Lei, Ma Zelong, Wu Xiaoming

机构信息

Laboratory of Molecular Genetics of Aging & Tumor, Medical School, Kunming University of Science and Technology, Chenggong Campus, 727 South Jingming Road, Kunming 650500, China.

出版信息

Genes (Basel). 2024 Dec 17;15(12):1615. doi: 10.3390/genes15121615.

DOI:10.3390/genes15121615
PMID:39766882
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11675497/
Abstract

The tumor secretome comprises the totality of protein factors secreted by various cell components within the tumor microenvironment, serving as the primary medium for signal transduction between tumor cells and between tumor cells and stromal cells. The deletion or mutation of the gene leads to alterations in cellular secretion characteristics, contributing to the construction of the tumor microenvironment in a cell non-autonomous manner. This review discusses the critical roles of mutant p53 in regulating the tumor secretome to remodel the tumor microenvironment, drive tumor progression, and influence the plasticity of cancer-associated fibroblasts (CAFs) as well as the dynamics of tumor immunity by focusing on both secreted protein expression and secretion pathways. The aim is to provide new insights for targeted cancer therapies.

摘要

肿瘤分泌组包含肿瘤微环境中各种细胞成分分泌的全部蛋白质因子,是肿瘤细胞之间以及肿瘤细胞与基质细胞之间信号转导的主要介质。该基因的缺失或突变会导致细胞分泌特征的改变,以非细胞自主方式参与肿瘤微环境的构建。本综述通过聚焦分泌蛋白表达和分泌途径,探讨突变型p53在调节肿瘤分泌组以重塑肿瘤微环境、驱动肿瘤进展以及影响癌症相关成纤维细胞(CAF)的可塑性和肿瘤免疫动力学方面的关键作用。目的是为靶向癌症治疗提供新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bb7/11675497/779e9e9a5a1b/genes-15-01615-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bb7/11675497/435e768cf9b0/genes-15-01615-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bb7/11675497/779e9e9a5a1b/genes-15-01615-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bb7/11675497/435e768cf9b0/genes-15-01615-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bb7/11675497/779e9e9a5a1b/genes-15-01615-g002.jpg

相似文献

1
Mutant p53-Mediated Tumor Secretome: Bridging Tumor Cells and Stromal Cells.突变型p53介导的肿瘤分泌组:连接肿瘤细胞与基质细胞
Genes (Basel). 2024 Dec 17;15(12):1615. doi: 10.3390/genes15121615.
2
Interleukin-1β promotes ovarian tumorigenesis through a p53/NF-κB-mediated inflammatory response in stromal fibroblasts.白细胞介素-1β 通过 p53/NF-κB 介导的基质成纤维细胞炎症反应促进卵巢肿瘤发生。
Neoplasia. 2013 Apr;15(4):409-20. doi: 10.1593/neo.121228.
3
Mutant p53 proteins alter cancer cell secretome and tumour microenvironment: Involvement in cancer invasion and metastasis.突变型p53蛋白改变癌细胞分泌组和肿瘤微环境:参与癌症侵袭和转移。
Cancer Lett. 2016 Jul 1;376(2):303-9. doi: 10.1016/j.canlet.2016.03.046. Epub 2016 Apr 1.
4
Altered p53 functionality in cancer-associated fibroblasts contributes to their cancer-supporting features.肿瘤相关成纤维细胞中 p53 功能的改变有助于其支持肿瘤的特性。
Proc Natl Acad Sci U S A. 2018 Jun 19;115(25):6410-6415. doi: 10.1073/pnas.1719076115. Epub 2018 Jun 4.
5
A framework for advancing our understanding of cancer-associated fibroblasts.推进我们对癌症相关成纤维细胞理解的框架。
Nat Rev Cancer. 2020 Mar;20(3):174-186. doi: 10.1038/s41568-019-0238-1. Epub 2020 Jan 24.
6
Noncanonical TGFβ Pathway Relieves the Blockade of IL1β/TGFβ-Mediated Crosstalk between Tumor and Stroma: TGFBR1 and TAK1 Inhibition in Colorectal Cancer.非经典 TGFβ 通路缓解了 IL1β/TGFβ 介导的肿瘤与基质间串扰的阻断:结直肠癌中的 TGFBR1 和 TAK1 抑制。
Clin Cancer Res. 2019 Jul 15;25(14):4466-4479. doi: 10.1158/1078-0432.CCR-18-3957. Epub 2019 Apr 12.
7
Functional heterogeneity of fibroblasts in primary tumors and metastases.原发性肿瘤和转移灶中,成纤维细胞的功能异质性。
Trends Cancer. 2025 Feb;11(2):135-153. doi: 10.1016/j.trecan.2024.11.005. Epub 2024 Dec 13.
8
p53's Extended Reach: The Mutant p53 Secretome.p53 的延伸作用:突变 p53 分泌组。
Biomolecules. 2020 Feb 15;10(2):307. doi: 10.3390/biom10020307.
9
Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.全面剖析癌症生物学:解析肿瘤微环境,以实现肿瘤学临床的有效癌症治疗。
OMICS. 2020 Apr;24(4):175-179. doi: 10.1089/omi.2020.0019. Epub 2020 Mar 13.
10
Fibroblasts in cancer: Defining target structures for therapeutic intervention.癌症中的成纤维细胞:治疗干预的目标结构定义。
Biochim Biophys Acta Rev Cancer. 2019 Aug;1872(1):111-121. doi: 10.1016/j.bbcan.2019.06.003. Epub 2019 Jun 29.

本文引用的文献

1
Interleukin-34-orchestrated tumor-associated macrophage reprogramming is required for tumor immune escape driven by p53 inactivation.白细胞介素 34 协调的肿瘤相关巨噬细胞重编程是由 p53 失活驱动的肿瘤免疫逃逸所必需的。
Immunity. 2024 Oct 8;57(10):2344-2361.e7. doi: 10.1016/j.immuni.2024.08.015. Epub 2024 Sep 24.
2
An engineered DNA aptamer-based PROTAC for precise therapy of p53-R175H hotspot mutant-driven cancer.一种基于工程化 DNA 适体的 PROTAC,用于精准治疗 p53-R175H 热点突变驱动的癌症。
Sci Bull (Beijing). 2024 Jul 15;69(13):2122-2135. doi: 10.1016/j.scib.2024.05.017. Epub 2024 May 18.
3
A synergistic two-drug therapy specifically targets a DNA repair dysregulation that occurs in p53-deficient colorectal and pancreatic cancers.
一种协同的两药疗法专门针对 p53 缺陷型结直肠和胰腺癌细胞中发生的 DNA 修复失调。
Cell Rep Med. 2024 Mar 19;5(3):101434. doi: 10.1016/j.xcrm.2024.101434. Epub 2024 Feb 21.
4
Cell fate regulation governed by p53: Friends or reversible foes in cancer therapy.p53 调控的细胞命运:癌症治疗中的朋友还是可逆的敌人?
Cancer Commun (Lond). 2024 Mar;44(3):297-360. doi: 10.1002/cac2.12520. Epub 2024 Feb 4.
5
Transcending frontiers in prostate cancer: the role of oncometabolites on epigenetic regulation, CSCs, and tumor microenvironment to identify new therapeutic strategies.超越前列腺癌的前沿:代谢物在表观遗传调控、CSCs 和肿瘤微环境中的作用,以确定新的治疗策略。
Cell Commun Signal. 2024 Jan 12;22(1):36. doi: 10.1186/s12964-023-01462-0.
6
Regulated secretion of mutant p53 negatively affects T lymphocytes in the tumor microenvironment.突变型 p53 的调控分泌会对肿瘤微环境中的 T 淋巴细胞产生负面影响。
Oncogene. 2024 Jan;43(2):92-105. doi: 10.1038/s41388-023-02886-1. Epub 2023 Nov 11.
7
Combining preclinical tools and models to unravel tumor complexity: Jump into the next dimension.结合临床前工具和模型来揭示肿瘤的复杂性:进入下一个维度。
Front Immunol. 2023 Mar 24;14:1171141. doi: 10.3389/fimmu.2023.1171141. eCollection 2023.
8
Specific regulation of BACH1 by the hotspot mutant p53 reveals a distinct gain-of-function mechanism.热点突变 p53 特异性调控 BACH1 揭示了一种独特的获得性功能机制。
Nat Cancer. 2023 Apr;4(4):564-581. doi: 10.1038/s43018-023-00532-z. Epub 2023 Mar 27.
9
GOF Mutant p53 in Cancers: A Therapeutic Challenge.癌症中的功能获得性突变型p53:一项治疗挑战。
Cancers (Basel). 2022 Oct 18;14(20):5091. doi: 10.3390/cancers14205091.
10
Constitutive Activation of the Tumor Suppressor p53 in Hepatocytes Paradoxically Promotes Non-Cell Autonomous Liver Carcinogenesis.肿瘤抑制因子 p53 在肝细胞中的组成性激活,反而促进了非细胞自主的肝癌发生。
Cancer Res. 2022 Aug 16;82(16):2860-2873. doi: 10.1158/0008-5472.CAN-21-4390.